EUCLISES Trademark

Trademark Overview

On Thursday, October 30, 2014, a trademark application was filed for EUCLISES with the United States Patent and Trademark Office. The USPTO has given the EUCLISES trademark a serial number of 86439696. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 25, 2024. This trademark is owned by Euclises Pharmaceuticals, Inc.. The EUCLISES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development
euclises

General Information

Serial Number86439696
Word MarkEUCLISES
Filing DateThursday, October 30, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 25, 2024
Registration Number5438543
Registration DateTuesday, April 3, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 31, 2015

Trademark Statements

Goods and ServicesPharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 25, 2024
Primary Code042
First Use Anywhere DateTuesday, April 19, 2016
First Use In Commerce DateTuesday, April 19, 2016

Trademark Owner History

Party NameEuclises Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSt. Louis, MO 63108
Party NameEuclises Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSt. Louis, MO 63108
Party NameEuclises Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSt. Louis, MO 63108

Trademark Events

Event DateEvent Description
Tuesday, March 31, 2015PUBLISHED FOR OPPOSITION
Monday, November 3, 2014NEW APPLICATION ENTERED
Monday, November 10, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 20, 2015ASSIGNED TO EXAMINER
Friday, February 20, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 11, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 29, 2016SOU EXTENSION 2 GRANTED
Tuesday, March 31, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 26, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 24, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, November 24, 2015SOU EXTENSION 1 FILED
Tuesday, November 24, 2015SOU EXTENSION 1 GRANTED
Thursday, November 26, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 17, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, May 17, 2016SOU EXTENSION 2 FILED
Thursday, June 16, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 9, 2017SOU EXTENSION 4 GRANTED
Thursday, June 30, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 23, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, November 23, 2016SOU EXTENSION 3 FILED
Saturday, November 26, 2016SOU EXTENSION 3 GRANTED
Tuesday, November 29, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 24, 2017TEAS STATEMENT OF USE RECEIVED
Wednesday, May 24, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, May 24, 2017SOU EXTENSION 4 FILED
Wednesday, May 24, 2017USE AMENDMENT FILED
Friday, February 23, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, February 24, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 3, 2018REGISTERED-PRINCIPAL REGISTER
Monday, April 3, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, October 25, 2024CANCELLED SEC. 8 (6-YR)
Thursday, February 1, 2018STATEMENT OF USE PROCESSING COMPLETE
Saturday, June 10, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 2, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

euclises development research pharmaceutical